Ultrasound-Assisted Extraction of Cannabinoids from Cannabis Sativa for Medicinal Purpose
- PMID: 36559212
- PMCID: PMC9785504
- DOI: 10.3390/pharmaceutics14122718
Ultrasound-Assisted Extraction of Cannabinoids from Cannabis Sativa for Medicinal Purpose
Abstract
Over the past 20 years, the interest in Cannabis oily extracts for medicinal use compounded in pharmacy has consistently grown, along with the need to have preparations of adequate quality. Hot maceration (M) is the most frequently used method to compound oily solutions. In this work, we systematically studied the possibility of using an ultrasonic homogenizer and a sonotrode (US) as an alternative extraction method. Oily solutions were prepared using two available varieties of Cannabis for medicinal use, called FM2 and Bedrocan. All preparations resulted with an equivalent content in CBD and THC, with the advantage of a faster process using US. In particular, 10 min sonication at the amplitude optimized for the sonotrode used (2 or 7 mm) provides not statistically different total Δ9-tetrahydrocannabinol (M-FM2: 0.26 ± 0.02 % w/w; US-FM2: 0.19 ± 0.004 % w/w; M-Bedrocan: 1.83 ± 0.17 % w/w; US-Bedrocan: 1.98 ± 0.01 % w/w) and total cannabidiol (M-FM2: 0.59 ± 0.04 % w/w; US-FM2: 0.58 ± 0.01 % w/w) amounts extracted in refined olive oil. It can therefore be confirmed that sonotrode is an efficient and fast extraction technique and its use is without negative consequence on the solvent properties. Despite DSC evidencing that both maceration and sonication modify the Tonset and enthalpy of the event at about -10 °C, the qualitative characteristics of the oil remained constant for the two treatments and similar to the starting material.
Keywords: Bedrocan; DSC; FM2; lipophilic volatile carbonyl compounds; oil characterization; oxidized fatty acids; sonotrode; tocopherol.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Digital Technologies Applied to Control the One-Step Process of Cannabis Olive Oil Preparations.Pharmaceutics. 2023 Mar 8;15(3):870. doi: 10.3390/pharmaceutics15030870. Pharmaceutics. 2023. PMID: 36986731 Free PMC article.
-
Neuroprotective Effects of Cannabidiol but Not Δ9-Tetrahydrocannabinol in Rat Hippocampal Slices Exposed to Oxygen-Glucose Deprivation: Studies with Cannabis Extracts and Selected Cannabinoids.Int J Mol Sci. 2021 Sep 9;22(18):9773. doi: 10.3390/ijms22189773. Int J Mol Sci. 2021. PMID: 34575932 Free PMC article.
-
Therapeutic Use of Δ9-THC and Cannabidiol: Evaluation of a New Extraction Procedure for the Preparation of Cannabis-based Olive Oil.Curr Pharm Biotechnol. 2017;18(10):828-833. doi: 10.2174/1389201019666171129175655. Curr Pharm Biotechnol. 2017. PMID: 29189144
-
Medicinal Applications of Cannabinoids Extracted from Cannabis sativa (L.): A New Route in the Fight Against COVID-19?Curr Pharm Des. 2021;27(13):1564-1578. doi: 10.2174/1381612826666201202125807. Curr Pharm Des. 2021. PMID: 33267756 Review.
-
Using the BMD Approach to Derive Acceptable Daily Intakes of Cannabidiol (CBD) and Tetrahydrocannabinol (THC) Relevant to Electronic Cigarette Liquids.Front Biosci (Landmark Ed). 2022 Jul 25;27(8):228. doi: 10.31083/j.fbl2708228. Front Biosci (Landmark Ed). 2022. PMID: 36042166
Cited by
-
Recent HPLC-UV Approaches for Cannabinoid Analysis: From Extraction to Method Validation and Quantification Compliance.Pharmaceuticals (Basel). 2025 May 24;18(6):786. doi: 10.3390/ph18060786. Pharmaceuticals (Basel). 2025. PMID: 40573182 Free PMC article. Review.
-
Assisted Extraction of Hemp Oil and Its Application to Design Functional Gluten-Free Bakery Foods.Molecules. 2025 Jun 19;30(12):2665. doi: 10.3390/molecules30122665. Molecules. 2025. PMID: 40572627 Free PMC article.
References
-
- Ferber S.G., Namdar D., Hen-Shoval D., Eger G., Koltai H., Shoval G., Shbiro L., Weller A. The “Entourage Effect”: Terpenes Coupled with Cannabinoids for the Treatment of Mood Disorders and Anxiety Disorders. Curr. Neuropharmacol. 2020;18:87–96. doi: 10.2174/1570159X17666190903103923. - DOI - PMC - PubMed
-
- Guerrero-Alba R., Barragan-Iglesias P., González-Hernández A., Valdez-Moráles E.E., Granados-Soto V., Condés-Lara M., Rodríguez M.G., Marichal-Cancino B.A. Some Prospective Alternatives for Treating Pain: The Endocannabinoid System and Its Putative Receptors GPR18 and GPR55. Front. Pharmacol. 2019;9:1496. doi: 10.3389/fphar.2018.01496. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous